162 related articles for article (PubMed ID: 38213281)
21. Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.
Durham BH; Hershkovitz-Rokah O; Abdel-Wahab O; Yabe M; Chung YR; Itchaki G; Ben-Sasson M; Asher-Guz VA; Groshar D; Doe-Tetteh SA; Alano T; Solit DB; Shpilberg O; Diamond EL; Mazor RD
Blood Adv; 2023 Dec; 7(23):7319-7328. PubMed ID: 37874915
[TBL] [Abstract][Full Text] [Related]
22. Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.
Willman CL; Busque L; Griffith BB; Favara BE; McClain KL; Duncan MH; Gilliland DG
N Engl J Med; 1994 Jul; 331(3):154-60. PubMed ID: 8008029
[TBL] [Abstract][Full Text] [Related]
23. Ophthalmic histiocytic lesions: a baseline demographic and clinicopathological study of 28 cases from two eye centers.
Alkatan HM; Alzahem TA; Maktabi AMY
Int Ophthalmol; 2022 Apr; 42(4):1221-1232. PubMed ID: 34727265
[TBL] [Abstract][Full Text] [Related]
24. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
Allen CE; Parsons DW
Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
Lau SK; Chu PG; Weiss LM
Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
[TBL] [Abstract][Full Text] [Related]
26. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
[TBL] [Abstract][Full Text] [Related]
27. Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.
Diamond EL; Durham BH; Haroche J; Yao Z; Ma J; Parikh SA; Wang Z; Choi J; Kim E; Cohen-Aubart F; Lee SC; Gao Y; Micol JB; Campbell P; Walsh MP; Sylvester B; Dolgalev I; Aminova O; Heguy A; Zappile P; Nakitandwe J; Ganzel C; Dalton JD; Ellison DW; Estrada-Veras J; Lacouture M; Gahl WA; Stephens PJ; Miller VA; Ross JS; Ali SM; Briggs SR; Fasan O; Block J; Héritier S; Donadieu J; Solit DB; Hyman DM; Baselga J; Janku F; Taylor BS; Park CY; Amoura Z; Dogan A; Emile JF; Rosen N; Gruber TA; Abdel-Wahab O
Cancer Discov; 2016 Feb; 6(2):154-65. PubMed ID: 26566875
[TBL] [Abstract][Full Text] [Related]
28. Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.
Bagnasco F; Zimmermann SY; Egeler RM; Nanduri VR; Cammarata B; Donadieu J; Lehrnbecher T; Haupt R
Eur J Cancer; 2022 Sep; 172():138-145. PubMed ID: 35772351
[TBL] [Abstract][Full Text] [Related]
29. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
[TBL] [Abstract][Full Text] [Related]
30. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.
Pileri SA; Grogan TM; Harris NL; Banks P; Campo E; Chan JK; Favera RD; Delsol G; De Wolf-Peeters C; Falini B; Gascoyne RD; Gaulard P; Gatter KC; Isaacson PG; Jaffe ES; Kluin P; Knowles DM; Mason DY; Mori S; Müller-Hermelink HK; Piris MA; Ralfkiaer E; Stein H; Su IJ; Warnke RA; Weiss LM
Histopathology; 2002 Jul; 41(1):1-29. PubMed ID: 12121233
[TBL] [Abstract][Full Text] [Related]
31. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells.
Durham BH; Roos-Weil D; Baillou C; Cohen-Aubart F; Yoshimi A; Miyara M; Papo M; Hélias-Rodzewicz Z; Terrones N; Ozkaya N; Dogan A; Rampal R; Urbain F; Le Fèvre L; Diamond EL; Park CY; Papo T; Charlotte F; Gorochov G; Taly V; Bernard OA; Amoura Z; Abdel-Wahab O; Lemoine FM; Haroche J; Emile JF
Blood; 2017 Jul; 130(2):176-180. PubMed ID: 28566492
[TBL] [Abstract][Full Text] [Related]
32. Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016.
Tzankov A; Kremer M; Leguit R; Orazi A; van der Walt J; Gianelli U; Hebeda KM
Ann Hematol; 2018 Nov; 97(11):2117-2128. PubMed ID: 30084011
[TBL] [Abstract][Full Text] [Related]
33. Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia.
Kazama S; Yokoyama K; Ueki T; Kazumoto H; Satomi H; Sumi M; Ito I; Yusa N; Kasajima R; Shimizu E; Yamaguchi R; Imoto S; Miyano S; Tanaka Y; Denda T; Ota Y; Tojo A; Kobayashi H
Front Oncol; 2022; 12():974307. PubMed ID: 36185232
[TBL] [Abstract][Full Text] [Related]
34. A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor.
Cheng F; Yu F; Wang X; Huang K; Lu H; Wang Z
Int J Surg Pathol; 2021 Dec; 29(8):906-914. PubMed ID: 33939500
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature.
Castro EC; Blazquez C; Boyd J; Correa H; de Chadarevian JP; Felgar RE; Graf N; Levy N; Lowe EJ; Manning JT; Proytcheva MA; Senger C; Shayan K; Sterba J; Werner A; Surti U; Jaffe R
Pediatr Dev Pathol; 2010; 13(3):225-37. PubMed ID: 19642834
[TBL] [Abstract][Full Text] [Related]
36. Histiocytic and dendritic cell neoplasms of the mediastinum.
Baraban E; Cooper K
Mediastinum; 2020; 4():12. PubMed ID: 35118280
[TBL] [Abstract][Full Text] [Related]
37. [Reactive and neoplastic histiocytic diseases in the dog].
Schwens Ch; Thom N; Moritz A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2011; 39(3):176-90. PubMed ID: 22143627
[TBL] [Abstract][Full Text] [Related]
38. Pediatric liver failure with massive sinusoidal infiltration of histiocytes.
Irie R; Shioda Y; Osumi T; Sakamoto KI; Kasahara M; Matsumoto K; Nakazawa A
J Clin Exp Hematop; 2022 Mar; 62(1):25-34. PubMed ID: 34840207
[TBL] [Abstract][Full Text] [Related]
39. The histiocytoses: clinical presentation and differential diagnosis.
Gonzalez CL; Jaffe ES
Oncology (Williston Park); 1990 Nov; 4(11):47-60; discussion 60, 62. PubMed ID: 2150325
[TBL] [Abstract][Full Text] [Related]
40. Histiocytic disorders of the gastrointestinal tract.
Detlefsen S; Fagerberg CR; Ousager LB; Lindebjerg J; Marcussen N; Nathan T; Sørensen FB
Hum Pathol; 2013 May; 44(5):683-96. PubMed ID: 23063502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
